Diagnosis prevention and treatment for PICC-related upper extremity deep vein thrombosis in breast cancer patients

2012 ◽  
Vol 8 (3) ◽  
pp. e12-e16 ◽  
Author(s):  
Lei XING ◽  
Vishnu Prasad ADHIKARI ◽  
Hong LIU ◽  
Ling Quan KONG ◽  
Sheng Chun LIU ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Deep Vein Thrombosis ◽  
Cancer Patients ◽  
Upper Extremity ◽  
Breast Cancer Patients ◽  
Vein Thrombosis ◽  
Prevention And Treatment ◽  
Deep Vein

scholarly journals Upper-extremity deep vein thrombosis related to central venous port systems implanted in cancer patients

2010 ◽  
Vol 83 (994) ◽  
pp. 850-853 ◽  
Author(s):  
S Yukisawa ◽  
Y Fujiwara ◽  
Y Yamamoto ◽  
T Ueno ◽  
K Matsueda ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Cancer Patients ◽  
Upper Extremity ◽  
Central Venous ◽  
Vein Thrombosis ◽  
Central Venous Port ◽  
Venous Port ◽  
Port Systems ◽  
Deep Vein

scholarly journals Tailored approach to the choice of long-term vascular access in breast cancer patients

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0255004
Author(s):  
Hyangkyoung Kim ◽  
Sukyung Kwon ◽  
Soo Mi Son ◽  
Eunseon Jeong ◽  
Jang-Yong Kim
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Vascular Access ◽  
Blood Stream Infection ◽  
Clinical Situation ◽  
Blood Stream ◽  
Breast Cancer Patients ◽  
Vein Thrombosis ◽  
Chest Port ◽  
Deep Vein

This study compared the possible options for vascular access in breast cancer patients by analyzing the complications of each method. We retrospectively evaluated the vascular access procedures for intravenous chemotherapy in breast cancer patients from 2016 to 2018. A total of 300 consecutive patients were included, 100 each who received peripherally inserted central catheters (PICCs), arm ports, and chest ports. When selecting a catheter, a PICC was considered when four cycles of chemotherapy were expected. Otherwise, patient preference was considered. All but one patient with an arm port were women, with mean age of 51.7 ± 9.1 years. The total mean complication-free catheter indwelling time was 1357.6 days for chest ports, 997.8 days for arm ports, and 366.8 days for PICCs (p = 0.004). There were 11 catheter-related complications (3.7%), one in a chest port patient, five in arm port patients, and eight in PICC patients. There was no patient with catheter related blood stream infection or deep vein thrombosis. All three types of catheters could be used in breast cancer patients without causing serious complications. The selection of catheter considering the clinical situation was effective for providing a safe and secure chemotherapy delivery route.

Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients

2015 ◽  
Vol 135 (2) ◽  
pp. 298-302 ◽  
Author(s):  
Aurélien Delluc ◽  
Grégoire Le Gal ◽  
Dimitrios Scarvelis ◽  
Marc Carrier
Keyword(s):  
Deep Vein Thrombosis ◽  
Central Venous Catheter ◽  
Cancer Patients ◽  
Upper Extremity ◽  
Venous Catheter ◽  
Central Venous ◽  
Vein Thrombosis ◽  
Deep Vein

scholarly journals Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port Catheters

2018 ◽  
Vol 12 ◽  
pp. 117822341877190 ◽  
Author(s):  
Danielle Tippit ◽  
Eric Siegel ◽  
Daniella Ochoa ◽  
Angela Pennisi ◽  
Erica Hill ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Deep Vein Thrombosis ◽  
Upper Extremity ◽  
Venous Access ◽  
High Risk Population ◽  
Safe Delivery ◽  
Vein Thrombosis ◽  
Venous Access Device ◽  
Deep Vein ◽  
Active Cancer

Most of the patients undergoing treatment for cancer require placement of a totally implantable venous access device to facilitate safe delivery of chemotherapy. However, implantable ports also increase the risk of deep vein thrombosis and related complications in this high-risk population. The objective of this study was to assess the incidence of upper-extremity deep vein thrombosis (UEDVT) in patients with breast cancer to determine whether the risk of UEDVT was higher with chest versus arm ports, as well as to determine the importance of previously reported risk factors predisposing to UEDVT in the setting of active cancer. We retrospectively reviewed the medical records of 297 women with breast cancer who had ports placed in our institution between the dates of December 1, 2010, and December 31, 2016. The primary outcome was the development of radiologically confirmed UEDVT ipsilateral to the implanted port. Overall, 17 of 297 study subjects (5.7%) were found to have UEDVT. There was 1 documented case of associated pulmonary embolism. Fourteen (9.5%) of 147 subjects with arm ports experienced UEDVT compared with only 3 (2.0%) of 150 subjects with chest ports ( P = .0056). Thus, implantation of arm ports as opposed to chest ports may be associated with a higher rate of UEDVT in patients with breast cancer.

scholarly journals Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH

2014 ◽  
Vol 12 (5) ◽  
pp. 796-800 ◽  
Author(s):  
J. I. Zwicker ◽  
G. Connolly ◽  
M. Carrier ◽  
P. W. Kamphuisen ◽  
A. Y. Y. Lee
Keyword(s):  
Deep Vein Thrombosis ◽  
Cancer Patients ◽  
Upper Extremity ◽  
Vein Thrombosis ◽  
Deep Vein

scholarly journals Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19

Viruses ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 878
Author(s):  
Yesha H. Parekh ◽  
Nicole J. Altomare ◽  
Erin P. McDonnell ◽  
Martin J. Blaser ◽  
Payal D. Parikh
Keyword(s):  
Deep Vein Thrombosis ◽  
Lower Extremity ◽  
Upper Extremity ◽  
Thromboembolic Events ◽  
Vein Thrombosis ◽  
Venous Thromboembolic Events ◽  
Venous Thromboembolic ◽  
Deep Vein

Infection with SARS-CoV-2 leading to COVID-19 induces hyperinflammatory and hypercoagulable states, resulting in arterial and venous thromboembolic events. Deep vein thrombosis (DVT) has been well reported in COVID-19 patients. While most DVTs occur in a lower extremity, involvement of the upper extremity is uncommon. In this report, we describe the first reported patient with an upper extremity DVT recurrence secondary to COVID-19 infection.

Prevalence and clinical outcomes of hospitalized patients with Upper-Extremity Deep Vein Thrombosis

2021 ◽  
Author(s):  
Rafael S. Cires-Drouet ◽  
Frederick Durham ◽  
Jashank Sharma ◽  
Praveen Cheeka ◽  
Zachary Strumpf ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Clinical Outcomes ◽  
Upper Extremity ◽  
Hospitalized Patients ◽  
Vein Thrombosis ◽  
Deep Vein
Sign in / Sign up

Export Citation Format

Share Document